Literature DB >> 32978253

Peptidoglycan analysis reveals that synergistic deacetylase activity in vegetative Clostridium difficile impacts the host response.

Héloise Coullon1, Aline Rifflet2, Richard Wheeler2, Claire Janoir1, Ivo G Boneca2, Thomas Candela3.   

Abstract

Clostridium difficile is an anaerobic and spore-forming bacterium responsible for 15-25% of postantibiotic diarrhea and 95% of pseudomembranous colitis. Peptidoglycan is a crucial element of the bacterial cell wall that is exposed to the host, making it an important target for the innate immune system. The C. difficile peptidoglycan is largely N-deacetylated on its glucosamine (93% of muropeptides) through the activity of enzymes known as N-deacetylases, and this N-deacetylation modulates host-pathogen interactions, such as resistance to the bacteriolytic activity of lysozyme, virulence, and host innate immune responses. C. difficile genome analysis showed that 12 genes potentially encode N-deacetylases; however, which of these N-deacetylases are involved in peptidoglycan N-deacetylation remains unknown. Here, we report the enzymes responsible for peptidoglycan N-deacetylation and their respective regulation. Through peptidoglycan analysis of several mutants, we found that the N-deacetylases PdaV and PgdA act in synergy. Together they are responsible for the high level of peptidoglycan N-deacetylation in C. difficile and the consequent resistance to lysozyme. We also characterized a third enzyme, PgdB, as a glucosamine N-deacetylase. However, its impact on N-deacetylation and lysozyme resistance is limited, and its physiological role remains to be dissected. Finally, given the influence of peptidoglycan N-deacetylation on host defense against pathogens, we investigated the virulence and colonization ability of the mutants. Unlike what has been shown in other pathogenic bacteria, a lack of N-deacetylation in C. difficile is not linked to a decrease in virulence.
© 2020 Coullon et al.

Entities:  

Keywords:  Clostridium difficile; N-deacetylase; bacteria; bacterial metabolism; bacterial pathogenesis; cell wall; lysozyme; peptidoglycan; virulence

Mesh:

Substances:

Year:  2020        PMID: 32978253      PMCID: PMC7864072          DOI: 10.1074/jbc.RA119.012442

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Analysis of the peptidoglycan structure of Bacillus subtilis endospores.

Authors:  D L Popham; J Helin; C E Costello; P Setlow
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

2.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

Authors:  S B Debast; M P Bauer; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2014-03       Impact factor: 8.067

3.  Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan.

Authors:  Thomas Candela; Agnès Fouet
Journal:  Mol Microbiol       Date:  2005-08       Impact factor: 3.501

4.  A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile.

Authors:  Stephen T Cartman; Nigel P Minton
Journal:  Appl Environ Microbiol       Date:  2009-12-18       Impact factor: 4.792

5.  Significant contribution of the pgdA gene to the virulence of Streptococcus suis.

Authors:  Nahuel Fittipaldi; Tsutomu Sekizaki; Daisuke Takamatsu; María de la Cruz Domínguez-Punaro; Josée Harel; Nhat Khai Bui; Waldemar Vollmer; Marcelo Gottschalk
Journal:  Mol Microbiol       Date:  2008-12       Impact factor: 3.501

Review 6.  Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.

Authors:  Marie Céline Zanella Terrier; Martine Louis Simonet; Philippe Bichard; Jean Louis Frossard
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 7.  Clostridium difficile: a European perspective.

Authors:  A M Jones; E J Kuijper; M H Wilcox
Journal:  J Infect       Date:  2012-10-24       Impact factor: 6.072

8.  Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores.

Authors:  Trevor D Lawley; Nicholas J Croucher; Lu Yu; Simon Clare; Mohammed Sebaihia; David Goulding; Derek J Pickard; Julian Parkhill; Jyoti Choudhary; Gordon Dougan
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

9.  Clostridium difficile in ground meat, France.

Authors:  Sylvie Bouttier; Marie-Claude Barc; Benjamin Felix; Sylvie Lambert; Anne Collignon; Frédéric Barbut
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

10.  Transcriptional analysis of temporal gene expression in germinating Clostridium difficile 630 endospores.

Authors:  Marcin Dembek; Richard A Stabler; Adam A Witney; Brendan W Wren; Neil F Fairweather
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more
  4 in total

Review 1.  Activation of the extracytoplasmic function σ factor σV by lysozyme in Clostridioides difficile.

Authors:  Theresa D Ho; Craig D Ellermeier
Journal:  Curr Opin Microbiol       Date:  2021-12-08       Impact factor: 7.934

2.  The WalRK Two-Component System Is Essential for Proper Cell Envelope Biogenesis in Clostridioides difficile.

Authors:  Ute Müh; Craig D Ellermeier; David S Weiss
Journal:  J Bacteriol       Date:  2022-05-16       Impact factor: 3.476

3.  Activation of the Extracytoplasmic Function σ Factor σV in Clostridioides difficile Requires Regulated Intramembrane Proteolysis of the Anti-σ Factor RsiV.

Authors:  Anthony G Pannullo; Craig D Ellermeier
Journal:  mSphere       Date:  2022-03-23       Impact factor: 5.029

4.  Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection.

Authors:  Wichuda Phothichaisri; Surang Chankhamhaengdecha; Tavan Janvilisri; Jirayu Nuadthaisong; Tanaporn Phetruen; Robert P Fagan; Sittinan Chanarat
Journal:  Microbiol Spectr       Date:  2022-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.